• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.26% Nasdaq Up0.23%

    More On PGL.AX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Progen Pharmaceuticals Limited (PGL.AX)

    0.19 Down 0.02(7.50%) 12:06AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Progen Pharmaceuticals Limited
    2806 Ipswich Road
    Darra, QLD 4076
    Australia - Map
    Phone: 61 7 3273 9133
    Fax: 61 7 3375 1168
    Website: http://www.progen-pharma.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Progen Pharmaceuticals Limited, a biotechnology company, discovers, researches, and develops biopharmaceutical therapeutics for the treatment of human diseases in Australia and the United States. It focuses on the development of the anti-angiogenesis and anti-metastatic oncology products pipeline. The company’s products in research and development stage include PG545, an anti-cancer compound in preclinical development; and PI-88 melanoma program that is in Phase III clinical trial in post-resection liver cancer. It also provides contract services related to the process development, manufacture, and quality assurance of biological products. Progen Pharmaceuticals Limited is based in Darra, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Progen Pharmaceuticals Limited

    Key Executives 
    Mr. Indrajit Solomon Arulampalam ,
    Exec. Chairman, Chairman of Remuneration Committee and Member of Audit Committee
    Ms. Fleur Lankesheer BSc LLB,
    Director of Legal & Bus. Devel.
    Mr. Leslie Tillack BSc BE (Chem),
    Chief Exec. Officer of PharmaSynth Pty Ltd
    Mr. Blair Lucas BA (Hons), LLB, GradDipEd (Sec), ACIS,
    Company Sec.
    Dr. Keith Dredge BSc Ph.D.,
    Director of Drug Devel.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.